Wellgistics Health Statistics
Total Valuation
WGRX has a market cap or net worth of $14.45 million. The enterprise value is $38.99 million.
Important Dates
The next estimated earnings date is Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WGRX has 125.67 million shares outstanding. The number of shares has increased by 50.23% in one year.
| Current Share Class | 125.67M |
| Shares Outstanding | 125.67M |
| Shares Change (YoY) | +50.23% |
| Shares Change (QoQ) | +29.83% |
| Owned by Insiders (%) | 36.89% |
| Owned by Institutions (%) | 3.63% |
| Float | 66.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -115.61% |
| Return on Invested Capital (ROIC) | -231.35% |
| Return on Capital Employed (ROCE) | -11,952.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.09% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -97.09% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 39.06 |
| Average Volume (20 Days) | 30,845,905 |
Short Selling Information
The latest short interest is 15.63 million, so 12.44% of the outstanding shares have been sold short.
| Short Interest | 15.63M |
| Short Previous Month | 2.84M |
| Short % of Shares Out | 12.44% |
| Short % of Float | 23.57% |
| Short Ratio (days to cover) | 0.56 |
Income Statement
In the last 12 months, WGRX had revenue of $23.34 million and -$101.27 million in losses. Loss per share was -$1.43.
| Revenue | 23.34M |
| Gross Profit | -6.43M |
| Operating Income | -81.19M |
| Pretax Income | -101.27M |
| Net Income | -101.27M |
| EBITDA | -77.98M |
| EBIT | -81.19M |
| Loss Per Share | -$1.43 |
Full Income Statement Balance Sheet
The company has $42,571 in cash and $24.58 million in debt, giving a net cash position of -$24.54 million or -$0.20 per share.
| Cash & Cash Equivalents | 42,571 |
| Total Debt | 24.58M |
| Net Cash | -24.54M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | -12.45M |
| Book Value Per Share | -0.12 |
| Working Capital | -26.96M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -10.86M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.21M |
| Net Borrowing | -2.11M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | -27.54% |
| Operating Margin | -347.91% |
| Pretax Margin | -433.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |